Clinical Trial Update: Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol [Phase 4]

View source ↗

Summary

A Phase 4 study comparing Welchol (colesevelam) plus TriCor (fenofibrate) to TriCor alone in patients with hypercholesterolemia and hyperlipidemia has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Combined Hyperlipidemia
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Tricor (fenofibrate)
• Welchol (colesevelam hydrochloride)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Hypercholesterolemia, Hyperlipidemia, Familial Combined | Phase 4 | Status: COMPLETED